The bottleneck in AZT activation


Nucleoside-based inhibitors of reverse transcriptase were the first drugs to be used in the chemotherapy of AIDS. After entering the cell, these substances are activated to their triphosphate form by cellular kinases, after which they are potent chain terminators for the growing viral DNA (ref. 1). The two main factors limiting their efficacy are probably interrelated. These are the insufficient degree of reduction of viral load at the commencement of treatment and the emergence of resistant variants of the virus. The reason for the relatively poor suppression of viral replication appears to be inefficient metabolic activation. Thus, for the most extensively used drug, 3′-azido-3′-de-oxythymidine (AZT), whereas phosphorylation to the monophosphate is facile, the product is a very poor substrate for the next kinase in the cascade, thymidylate kinase2,3. Because of this, although high concentrations of the monophosphate can be reached in the cell, the achievable concentration of the active triphosphate is several orders of magnitude lower. Determination of the structure of thymidylate kinase as a complex with AZT monophosphate (AZTMP) together with studies on the kinetics of its phosphorylation have now led to a detailed understanding of the reasons for and consequences of the poor substrate properties.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Tornevik, Y., Ullman, B., Balzarini, J., Wahren, B. & Eriksson, S. Cytotoxicity of 3′-azido-3′-deoxythymidine correlates with 3′-azidothymidine-5′-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3′-azidothymidine-5′-triphosphate (AZTTP) levels in cultured CEM T-lym-phoblastoid cells. Biochem. Pharmacol. 49, 829–837 (1995).

  2. 2

    Furman, P.A. et al. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl. Acad. Sci. USA 83, 8333–8337 (1986).

  3. 3

    Qian, M., Bui, T., Ho, R.J. & Unadkat, J.D. Metabolism of 3′-azido-3′-deoxythymi-dine (AZT) in human placental trophoblasts and Hofbauer cells. Biochem. Pharmacol. 48, 383–389 (1994).

  4. 4

    Lavie, A. et al. Crystal structure of thymidylate kinase reveals the cause behind the limiting step in AZT activation. Nature Struct. Biol. (in the press).

  5. 5

    Saraste, M., Sibbald, P.R. & Wittinghofer, A. The P-loop — a common motif in ATP-and GTP-binding proteins. Trends Biochem. Sci. 15, 430–434 (1990).

  6. 6

    Frick, L.W., Nelson, D.J., St Clair, M.H., Furman, P.A., Krenitsky, T.A. Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem. Biophys. Res. Commun. 154, 124–129 (1988).

  7. 7

    Van, J.P. et al. 3′-Azidothymidine (zidovudine) inhibits glycosylation and dramatically alters glycosphingolipid synthesis in whole cells at clinically relevant concentrations. J. Biol. Chem. 270, 22836–22841 (1995).

  8. 8

    Bridges, E.G., Faraj, A. & Sommadossi, J.P. Inhibition of mammalian DNA poly-merase-associated 3′ to 5′ exonuclease activity by 5′-monophosphates of 3′-azido-3′-deoxythymidine and 3′-amino-3′-deoxythymidine. Biochem. Pharmacol. 45, 1571–1576 (1993).

  9. 9

    Harrington, J.A., Reardon, J.E. & Spector, T. 3′-Azido-3′-deoxythymidine (AZT) monophosphate: An inhibitor of exonucleolytic repair of AZT-terminated DNA. Antimicrob. Agents Chemother. 37, 918–920 (1993).

  10. 10

    Miiller, B., Restle, T., Reinstein, J. & Goody, R.S. Interaction of fluorescently labeled dideoxynucleotides with HIV-1 reverse transcriptase. Biochemistr. 30, 3709–3715 (1991).

  11. 11

    Goody, R.S., Muller, B. & Restle, T. Factors contributing to the inhibition of HIV reverse transcriptase by chain-terminating nucleotides in vitro and in vivo. FEBS Lett. 291, 1–5 (1991).

  12. 12

    Nickel, W., Austermann, S., Bialek, G. & Grosse, F. Interactions of azidothymidine triphosphate with the cellular DNA polymerases alpha, delta, and epsilon and with DNA primase. J. Biol. Chem. 267, 848–854 (1992).

  13. 13

    Huang, P., Farquhar, D. & Plunkett, W. Selective action of 3′-azido-3′-deoxythymi-dine 5′-triphosphate on viral reverse transcriptases and human DNA polymerases. J. Biol. Chem. 265, 11914–11918 (1990).

  14. 14

    Clos, J. et al. Molecular cloning and expression of a hexameric Drosophila heat shock factor subject to negative regulation. Cell 63, 1085–1097 (1990).

  15. 15

    Studier, F.W., Rosenberg, A.H., Dunn, J.J. & Dubendorff, J.W. Use of T7 RNA poly-merase to direct expression of cloned genes. Methods Enzymol. 185, 60–89 (1990).

  16. 16

    Berghäuser, J. Identification of an active arginine in adenylate kinase. Biochim. Biophys. Acta 397, 370–376 (1975).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading